Chemours (CC) Other Accumulated Expenses (2015 - 2026)

Chemours has reported Other Accumulated Expenses for 12 years, with the latest figure at $97.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 17.09% year-over-year to $97.0 million; the trailing twelve-month figure through Mar 2026 stood at $97.0 million (down 17.09% YoY), and the FY2025 full-year result was $150.0 million, up 30.43% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $97.0 million, down from $150.0 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $239.0 million in Q2 2022, with the low at $74.0 million in Q4 2022.
• Average Other Accumulated Expenses over 5 years is $116.1 million, with a median of $115.0 million recorded in 2024.
• Year-over-year, Other Accumulated Expenses surged 191.46% in 2022 and sank 52.72% in 2023.
• Tracing CC's Other Accumulated Expenses over 5 years: stood at $74.0 million in 2022, then surged by 74.32% to $129.0 million in 2023, then fell by 10.85% to $115.0 million in 2024, then surged by 30.43% to $150.0 million in 2025, then slumped by 35.33% to $97.0 million in 2026.
• The last three Other Accumulated Expenses figures came in at $97.0 million (Q1 2026), $150.0 million (Q4 2025), and $107.0 million (Q3 2025), per Business Quant data.

Peer Comparison